These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 24034107

  • 1. Effects of low molecular weight heparin on clot rate and activated clotting time: an in vitro study.
    Shi XB, Bai Y, Li J, Xiao J, Wang JQ, Zheng H.
    Chin Med J (Engl); 2013; 126(18):3553-6. PubMed ID: 24034107
    [Abstract] [Full Text] [Related]

  • 2. [Sensitivity of new reagents for laboratory monitoring of low molecular weight heparin: an in vitro study].
    Shi XB, Wang JQ, Wang JY, Hou XX, Ma ZM.
    Zhonghua Yi Xue Za Zhi; 2011 Jun 14; 91(22):1566-8. PubMed ID: 21914372
    [Abstract] [Full Text] [Related]

  • 3. In vitro anticoagulation monitoring of low-molecular-weight heparin.
    Wang JQ, Shi XB, Yang JG, Hu DY.
    Chin Med J (Engl); 2009 May 20; 122(10):1199-202. PubMed ID: 19493471
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis.
    Frank RD, Brandenburg VM, Lanzmich R, Floege J.
    Nephrol Dial Transplant; 2004 Jun 20; 19(6):1552-8. PubMed ID: 15034159
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS, Murkin JM, Adams SJ.
    Heart Surg Forum; 2004 Jun 20; 7(6):E599-604. PubMed ID: 15769695
    [Abstract] [Full Text] [Related]

  • 10. Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses.
    Despotis GJ, Alsoufiev AL, Spitznagel E, Goodnough LT, Lappas DG.
    Ann Thorac Surg; 1996 Mar 20; 61(3):795-9. PubMed ID: 8619695
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H, Szlam F, Tanaka KA, van de Locht A, Ogawa S, Levy JH.
    Anesth Analg; 2012 Aug 20; 115(2):244-52. PubMed ID: 22584552
    [Abstract] [Full Text] [Related]

  • 13. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time.
    Jessen LR, Wiinberg B, Jensen AL, Kjelgaard-Hansen M, Jensen KH, Pedersen LB, Kristensen AT.
    Vet Clin Pathol; 2008 Dec 20; 37(4):363-72. PubMed ID: 19055570
    [Abstract] [Full Text] [Related]

  • 14. Pravastatin potentiates the anticoagulant effects of low molecular weight heparin.
    Zimmer JE, Spillert CR, Puppala S, Zamecki K, Bhatt BA, Arora RR.
    Thromb Res; 2004 Dec 20; 113(6):407-10. PubMed ID: 15226096
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration.
    Marmur JD, Anand SX, Bagga RS, Fareed J, Pan CM, Sharma SK, Richard MF.
    J Am Coll Cardiol; 2003 Feb 05; 41(3):394-402. PubMed ID: 12575965
    [Abstract] [Full Text] [Related]

  • 19. Use of viscoelastic coagulation testing to monitor low molecular weight heparin administration to healthy horses.
    Tennent-Brown BS, Epstein KL, Whelchel DD, Giguère S.
    J Vet Emerg Crit Care (San Antonio); 2013 Feb 05; 23(3):291-9. PubMed ID: 23656212
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.